BIM 26226
Latest Information Update: 14 Dec 2001
Price :
$50 *
At a glance
- Originator Biomeasure Inc
- Class Antineoplastics; Hormones
- Mechanism of Action Gastrin-releasing peptide inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer